by reason for retraction – Page 34

Urology researcher under investigation for double-dipping has another paper retracted

A urology researcher who stepped down from his post as department chair after an institutional investigation prompted by Retraction Watch reporting has lost another paper.

The article apparently was not flagged during a misconduct investigation, but a PubPeer commenter noted overlapping images in August 2021.

Hari Koul had been interim chair of the department of biochemistry and molecular biology at LSU Health New Orleans until last December. He stepped down from the post (but remains a professor) amid the university’s investigation of allegations that he secured grants from two federal agencies for the same research project, following reporting by Retraction Watch in October.

An LSU Health New Orleans spokesperson told Retraction Watch the “process has not been completed.”

‘Inadvertently published’ paper by pharma employee retracted almost a year later

A Takeda employee has lost a 2021 paper that the journal says it “inadvertently published.”

The article, “Seasonal and Secular Periodicities Identified in the Dynamics of US FDA Medical Devices (1976–2020): Portends Intrinsic Industrial Transformation and Independence of Certain Crises,” appeared in Therapeutic Innovation & Regulatory Science. It has yet to be cited, according to Clarivate Analytics’ Web of Science

The retraction notice from a few days ago says, in full:

Drug researchers in Russia have four papers subjected to expressions of concern

A psychiatry journal has issued expressions of concern for four papers by a group of researchers in Russia after questions surfaced about the integrity of the data.

The first author on all of the papers was Ilya D. Ionov, of the Centre On Theoretical Problems in Physical and Chemical Pharmacology, part of the Russian Academy of Sciences in Moscow. The co-authors are affiliated with Timpharm LTD, a drug company without much in the way of an online presence.

The papers appeared in Psychopharmacology, a Springer Nature title.

Here’s the notice for “Anticataleptic activity of nicotine in rats: involvement of the lateral entorhinal cortex,” which Psychopharmacology published in 2021:

The “internet may be a challenging venue”: Biomedical engineering group up to four retractions

A group of biomedical engineering researchers has lost four papers because they appear to be recycling their images from other papers.

The retractions for the group, from Banaras Hindu University in India, span papers published between 2011 and 2014. The retractions began in 2020, after anonymous PubPeer commenters pointed out the similarities between images. The four papers have been cited a total of 140 times, according to Clarivate Analytics’ Web of Science.

The latest paper to be retracted, “Alleviation of glutamate-mediated neuronal insult by piroxicam in rodent model of focal cerebral ischemia: a possible mechanism of GABA agonism,” was originally published in Springer Nature’s Journal of Physiology and Biochemistry in 2014. It has been cited 12 times.

According to the retraction notice:

How citation cartels give ‘strategic scholars’ an advantage: A simple model

Sincere scholars work to expand society’s knowledge and understanding. They cite all the relevant research, even that produced by those they disagree with or personally dislike. They encourage debate. For the sincere scholar, a citation is a responsibility, and proper and thorough citations demonstrate research quality.

For the strategic scholar, a citation is an asset to be used career-advantageously. As a certain former governor of the State of Illinois once said about his responsibility to fill an open US senate position, “I’ve got this thing and it’s (expletive) golden. I’m not just giving it up for (expletive) nothing.”

Strategic scholars cite the work of their friends, working colleagues, those they agree with, and those who reference them. Indeed, the most successful career-strategic scholars operate in groups of like-minded colleagues in which they promote each other’s careers together—citation cartels. They draw attention to that other work which supports their own and their careers.

Journal retracts paper listed on authorship for sale site following Retraction Watch report

An Elsevier journal has retracted a paper that was listed by a firm claiming to sell authorships months after we reported on the site.

On Sept. 7, 2021, we published a story about the company, Teziran. On Sept. 14, pseudonymous sleuth Artemisia Stricta wrote to Ioannis Ieropoulos, the editor of Sustainable Energy Technologies and Assessments, which had published one of eight papers listed by Teziran as “ready for acceptance”:

‘A terrifying experience’: A team of researchers does the right thing when they find an error

Mitch Brown was preparing last August to launch a follow-up study to a 2021 paper on coalitions when he found something in his computer coding that sent his stomach to his shoes.

As Brown, an experimental psychologist at the University of Arkansas, recalled for us:

Journal issues 55 expressions of concern at once

The journal Cureus has issued expressions of concern for a whopping 55 papers whose authorship has come into question.

The articles, including a couple like this one on COVID-19, were apparently submitted as part of an effort by Imam Abdulrahman Bin Faisal University, in Saudi Arabia, to pad the publishing resumes of its medical students – and perhaps the school’s own metrics – who targeted Cureus for reasons that aren’t now clear.

Here’s the notice for “Sylvian Fissure Lipoma: An Unusual Etiology of Seizures in Adults,” which the journal published in January 2022:

Dermatology journal calls for investigation into Bordeaux-INSERM work

Two and a half years after critics raised concerns, a dermatology journal says it has called on two French institutions to launch an inquiry into a 2017 paper.

The Journal of Investigative Dermatology has issued an expression of concern for the article, “NADPH Oxidase-1 Plays a Key Role in Keratinocyte Responses to UV Radiation and UVB-Induced Skin Carcinogenesis,” which it published in June 2017.

The authors of the group were led by Hamid Reza Rezvani, the head of the dermatology team at Université de Bordeaux, and a research director with INSERM, France’s publicly funded science agency.

According to the article’s abstract:

Journals acknowledge that a critical “reader” has a name: Elisabeth Bik

Followers of this blog know that “a reader” seems to be the force behind a huge number of retractions – and that, despite the apparent unwillingness of journals to name them, they are real people. One of the more prolific “readers” is Elisabeth Bik, the data sleuth whose efforts to identify problematic images has led to the removal of hundreds of dodgy papers.

Journals now seem more willing to give credit where it’s due, by identifying Bik – who has faced threats for her efforts – in their notices.

A few recent examples: Biomedicine & Pharmacotherapy, an Elsevier title, has name-checked Bik in a dozen retractions of papers dating back to 2017.

Share this:

Share this:

Share this:

Share this:

Share this:

Share this:

Share this:

Share this:

Share this:

Share this: